BMO Capital analyst Daniel DiCicco initiated coverage of Emerson (EMR) with a Market Perform rating and $150 price target implying 16% upside. The firm says Emerson has repositioned itself as a global automation and industrial software company. BMO does not see meaningful upside potential to estimates in 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- AI Daily: OpenAI said to work on alternative to GitHub
- AI in high-margin hardware should be concern to investors, says Barclays
- OpenAI’s ex-research chief targets AI-driven manufacturing automation, WSJ says
- Emerson Establishes New 364-Day $2 Billion Credit Facility
- Emerson price target raised to $155 from $145 at Stephens